Nityr

Active Ingredient(s): Nitisinone
FDA Approved: * July 26, 2017
Pharm Company: * CYCLE PHARMS LTD
Category: Genetic Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Nityr Overview

Nitisinone (INN), also known as NTBC (an abbreviation of its full chemical name), sold under the brand name Orfadin among others, is a medication used to slow the effects of hereditary tyrosinemia type 1 (HT-1). Contents 1 Uses 2 Adverse effects 3 Mechanism of action 4 History 5 Research 6 References 7 External links Uses Nitisinone is used to treat hereditary tyrosinemia type 1 (HT-1) in patients from all ages, in combination with dietary restriction of tyrosine and phenylalanine.&...

Read more Nityr Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Nitisinone

Recent Nityr Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Nityr: (3 results)

Sorted by National Drug Code

• 70709-000 Nityr 10 mg Oral Tablet by Cycle Pharmaceuticals Ltd.
• 70709-002 Nityr 2 mg Oral Tablet by Cycle Pharmaceuticals Ltd.
• 70709-005 Nityr 5 mg Oral Tablet by Cycle Pharmaceuticals Ltd.

Other drugs which contain Nitisinone or a similar ingredient: (2 results)

• NITISINONE 3 discussions
• ORFADIN Nitisinone1 discussion